
South San Francisco-based Exelixis has released nearly 18,000 strains of
"We had many long discussions within the company about how best to further develop the technology, and in the end we decided to release it for everyone in academia to use," says Greg Plowman, senior vice president of research at Exelixis. Researchers at for-profit firms, though, must still license the technology.
The strains, representing about half of all known fly genes, will be split between Indiana University's
Interested in reading more?
